Lisata reclaims China rights to solid tumor candidate ahead of acquisition
Lisata reclaims China rights to solid tumor candidate ahead of acquisition
Body unavailable. Use the original source.
Lisata reclaims China rights to solid tumor candidate ahead of acquisition
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.